Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 826–850 of 7,816 matching trials · page 34 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Development and Evaluation of Virtual Reality Experiences for Cognitive Stimulation at the Sociosanitary Center El Carme NCT06155721 Virtual Reality Cognitive Stimulation Program Runs in: Spain · 1 site |
NA other |
COMPLETED | 45 | Badalona Serveis Assistencials OTHER |
2026-06-11 |
|
Polyphenols and Cognitive Decline NCT06507254 Polyphenol Supplement; Placebo Supplement Runs in: United States · 1 site |
NA other |
RECRUITING | 300 | University of California, Los Angeles OTHER |
2026-06-11 |
|
Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients NCT07101380 Tablet-based Physical SuperBrain BOOM; Smartphone-based SuperBrain BOOM Runs in: South Korea · 4 sites |
NA other |
ACTIVE_NOT_RECRUITING | 45 | Ajou University School of Medicine OTHER |
2026-06-11 |
|
A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial NCT07206446 RiSolve Runs in: Ireland · 1 site |
NA other |
COMPLETED | 46 | University of Galway OTHER |
2026-06-11 |
|
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables NCT07533084 Runs in: Italy · 8 sites |
NA other |
NOT_YET_RECRUITING | 265 | Neuromed IRCCS OTHER |
2026-06-11 |
|
A Study of the Metabolic Reconstruction Oral Biologics (Gut-X-001) Medication in People With Alzheimer's Disease (ESCAPE-AD) NCT07591727 Gut-X-001 + Placebo capsule; Gut-X-001; Placebo |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 120 | Beijing Tiantan Hospital OTHER |
2026-06-11 |
|
Transcutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive Impairment NCT07642518 active transcutaneous auricular vagus nerve stimulation; sham trans... |
NA other |
NOT_YET_RECRUITING | 38 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School OTHER |
2026-06-11 |
|
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment NCT07643363 Temporal Interference Stimulation; Sham Temporal Interference Stimu... Runs in: China · 1 site |
NA other |
RECRUITING | 60 | Tianjin Huanhu Hospital OTHER |
2026-06-11 |
|
Natural History Study of Synucleinopathies NCT01799915 Runs in: Argentina; South Korea; Spain; United States · 8 sites |
NA other |
RECRUITING | 800 | NYU Langone Health OTHER |
2026-06-10 |
|
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients NCT04032626 Lenalidomide 10 mg; Placebo Runs in: United States · 2 sites |
PHASE2 other |
COMPLETED | 15 | St. Joseph's Hospital and Medical Center, Phoenix OTHER |
2026-06-10 |
|
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) NCT05303701 GV1001 Placebo; GV1001 1.12mg |
PHASE3 other |
NOT_YET_RECRUITING | 750 | Samsung Pharmaceutical Co., Ltd. INDUSTRY |
2026-06-10 |
|
Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes NCT05527405 The MapHabit System Runs in: United States · 1 site |
NA other |
COMPLETED | 50 | MapHabit, Inc. INDUSTRY |
2026-06-10 |
|
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia NCT05741853 Video-Implemented Script Training for Aphasia (VISTA); Lexical Retr... Runs in: Spain; United States · 3 sites |
NA other |
RECRUITING | 60 | Stephanie Grasso OTHER |
2026-06-10 |
|
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia NCT06511752 Psychosocial educational, support group and implementation of strategies Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 120 | University of Texas at Austin OTHER |
2026-06-10 |
|
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia NCT07434479 Mindfulness-Based Virtual Reality Intervention Runs in: United States · 2 sites |
NA other |
RECRUITING | 58 | Manhattan Psychiatric Center OTHER |
2026-06-10 |
|
Silkworm Pupa Powder Improves Alzheimer's Disease NCT07638449 Silkworm pupa powder Runs in: China · 1 site |
NA other |
NOT_YET_RECRUITING | 100 | Zhejiang Provincial Tongde Hospital OTHER |
2026-06-10 |
|
F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project) NCT02414178 F 18 T807 Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 130 | Washington University School of Medicine OTHER |
2026-06-09 |
|
Rapamycin - Effects on Alzheimer's and Cognitive Health NCT04629495 Rapamycin; Placebo Runs in: United States · 1 site |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 40 | The University of Texas Health Science Center at San Antonio OTHER |
2026-06-09 |
|
Tau PET Imaging in Opioid Use Disorder NCT05651516 18F-PI-2620 PET/CT Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 12 | University of Pennsylvania OTHER |
2026-06-09 |
|
Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease NCT05731440 18F-Fluselenamyl Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 60 | Washington University School of Medicine OTHER |
2026-06-09 |
|
WECARE: A Behavioral Intervention for Dementia Caregivers NCT05992467 Wellness Enhancement for Caregivers (WECARE) Runs in: United States · 1 site |
NA other |
COMPLETED | 48 | George Mason University OTHER |
2026-06-09 |
|
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1 NCT06129838 [11C]-CS1P1 Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | Washington University School of Medicine OTHER |
2026-06-09 |
|
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl NCT06439992 18F-Fluselenamyl Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Washington University School of Medicine OTHER |
2026-06-09 |
|
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients NCT06745583 EI-1071 tablet, oral Runs in: Taiwan · 2 sites |
PHASE2 other |
RECRUITING | 15 | Elixiron Immunotherapeutics Inc. INDUSTRY |
2026-06-09 |
|
Auto-calibrating System for Upper Limb Disability Assessment, Neurological and Occupational Rehabilitation NCT07636538 Auto-calibrating System for Upper Limb disability Assessment, neuro... |
NA other |
NOT_YET_RECRUITING | 30 | University of Pavia OTHER |
2026-06-09 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial